StockWatch
·
HomeLiveReports

AJANTA PHARMA LTD.

BSE: 532331

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-0.86560.411.1K1.7KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
17.3221.4425.5729.69Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q1 FY27
PeriodQ1 FY27Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue1.5K+23.4%1.2K-1.1%1.2K+1.0%1.2K+19.2%1.0K-8.0%1.1K-2.4%1.1K
Other Income70.82+174.9%25.76-65.7%75.03+84.7%40.63+126.6%17.93-46.0%33.23-17.6%40.34
Total Income1.6K+26.5%1.2K-4.9%1.3K+3.7%1.2K+21.1%1.0K-9.1%1.1K-2.9%1.2K
EXPENSES
Expenditure1.1K+24.9%909.89-6.5%973.30+5.8%920.20+14.5%803.72+0.1%803.00-6.6%860.05
Tax107.98+39.5%77.42+6.9%72.44-2.1%74.02+113.2%34.72-56.4%79.70+7.4%74.22
PROFIT
PBT423.45+31.3%322.46+0.2%321.97-2.1%328.99+44.2%228.15-31.3%332.15+7.4%309.20
Net Profit315.47+28.7%245.04-1.8%249.53-2.1%254.97+31.8%193.43-23.4%252.45+7.4%234.98
KEY METRICS
OPM %26.65%-1.61pp28.26%+4.53pp23.73%-3.53pp27.26%+2.64pp24.62%+0.89pp23.73%+2.93pp20.80%
NPM %20.23%+0.35pp19.88%+0.62pp19.26%-1.15pp20.41%+1.66pp18.75%-3.49pp22.24%+2.14pp20.10%
EPS25.25+28.8%19.61-1.9%19.98-2.1%20.41+32.0%15.46-23.3%20.16+7.5%18.75

Corporate Events

DividendAJANTPHARM
2026
5Aug

Dividend

BSE Filing ↗
DividendAJANTPHARM
2026
5Aug

₹32 / share

BSE Filing ↗
Board MeetingAJANTPHARM
2026
30Jul

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing ↗
Board MeetingAJANTPHARM
2026
16Jul

Board Meeting

The Forty-Seventh (47th) Annual General Meeting ("AGM") of t…

BSE Filing ↗
DividendAJANTPHARM
2025
10Nov

₹1 / share

BSE Filing ↗
Board MeetingAJANTPHARM
2025
3Nov

Board Meeting

Update on board meeting, declaration of interim dividend, fi…

BSE Filing ↗
DividendAJANTPHARM
2024
8Dec

₹2 / share

BSE Filing ↗
DividendAJANTPHARM
2024
6Nov

₹1 / share

BSE Filing ↗
Board MeetingAJANTPHARM
2024
28Oct

Board Meeting

Consider and approve unaudited consolidated and standalone f…

BSE Filing ↗
Board MeetingAJANTPHARM
2024
30Jul

Board Meeting

Consider and approve unaudited consolidated and standalone f…

BSE Filing ↗
Board MeetingAJANTPHARM
2024
2May

Board Meeting

consider and approve buy-back of Equity Shares and other mat…

BSE Filing ↗
DividendAJANTPHARM
2024
8Feb

₹26 / share

BSE Filing ↗
Board MeetingAJANTPHARM
2024
31Jan

Board Meeting

declaration of 2nd Interim Dividend for the financial year e…

BSE Filing ↗
Board MeetingAJANTPHARM
2023
31Oct

Board Meeting

Consider and approve Unaudited Consolidated and Standalone F…

BSE Filing ↗